Physician profile
Bryan E Labuda
NPI 1528074689
$1,019.26
in general payments reported to CMS, 2019-2025
21 companies · $10.20 in 2025
The $10.20 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $252 · 2021: $26.75 · 2023: $120 · 2024: $36.60 · 2025: $10.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $84.99 · Food and Beverage: $81.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $84.99 |
| Food and Beverage | $81.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $100.43 | 2020-2023 | |
| Cumberland Pharmaceuticals, INC. | $97.65 | 2019-2020 | |
| Abbvie INC. | $93.76 | 2019-2021 | |
| Amgen INC. | $84.67 | 2019-2023 | Evenity, Prolia |
| Vertical Pharmaceuticals, LLC | $75.35 | 2019-2020 | |
| Therapeuticsmd, INC. | $70.91 | 2019 | |
| Amag Pharmaceuticals, INC. | $67.53 | 2019 | |
| Allergan, INC. | $60.75 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.72 | 2019-2023 | |
| Organon LLC | $46.80 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $46.44 | 2019-2020 | |
| Avion Pharmaceuticals | $30.86 | 2019-2020 | |
| Roche Diagnostics Corporation | $29.08 | 2019 | |
| Lupin INC. | $26.78 | 2019 | |
| Exeltis, USA INC. | $24.09 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $23.68 | 2019 | |
| Minerva Surgical, INC | $23.24 | 2019 | |
| Pharmacosmos Therapeutics INC. | $19.06 | 2020 | |
| Becton, Dickinson and Company | $16.39 | 2020 | |
| Assertio Therapeutics, INC. | $14.62 | 2019 | |
| Ethicon US, LLC | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Labuda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.